Bayesian Capital Management’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
Bayesian Capital Management's EXEL Position: Q3 2025 in Review
Bayesian Capital Management sold out of Exelixis (EXEL) in Q3 2025, closing a stake of 63,600 shares — an estimated $2.8M sold.
Bayesian Capital Management first reported a position in EXEL in Q1 2016 and held it in 12 quarters. The position peaked at $2.8M in Q2 2025. 621 funds tracked by Wall St. Rank hold EXEL as of Q3 2025.
- Bayesian Capital Management reported no remaining Exelixis position as of Q3 2025 after selling out during the quarter.
- Bayesian Capital Management sold 63,600 Exelixis shares in Q3 2025, an estimated $2.8M.
- Bayesian Capital Management first reported a position in Exelixis in Q1 2016 and held it in 12 quarters.
- Bayesian Capital Management's Exelixis position peaked at $2.8M in Q2 2025.
- 621 funds tracked by Wall St. Rank held Exelixis as of Q3 2025.
Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.